Skip Navigation

Visiting Dana-Farber? See our prescreening and mask requirements.

Histiocytosis Overview

  • As a patient in the Adult Histiocyte Disorders Center, you will be treated by dedicated experts in the treatment of rare histiocyte diseases. The Center is part of Dana-Farber Brigham Cancer Center's world-class Hematologic Oncology Treatment Center, which provides highly specialized care — and conducts leading-edge research and clinical trials — for cancers of the blood.

    Individualized Treatment and Exceptional Care for Patients with Adult Histiocytosis

    • One of the world's largest and most experienced centers for the treatment of adult histiocytosis and histiocyte disorders
    • Unique multidisciplinary team approach, including medical oncology, pathology, surgical oncology, endocrinology, cardiology, nephrology, neurology, and pulmonology, orthopedics, and dermatology
    • Deep expertise in diagnosing and aggressively treating even the rarest histiocyte disorders
    • Genetic evaluation for patients based on personal or family history that suggests a risk for histiocyte disorders
    • Timely diagnosis and treatment — appointments as soon as the next business day
    • The very latest therapies, including clinical trials that may not be available elsewhere
    • Referrals from, and collaboration with, other leading national and international centers
    • The full expertise of two world-class medical centers — Dana-Farber Cancer Institute and Brigham and Women's Hospital

    We Treat You, Not Just Your Histiocytosis

    We offer many programs to support our patients and their families before, during, and after treatment, including: